Active, Not Recruiting
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
NCT06049212
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Aichi Cancer Center ( Site 0006) Nagoya, Aichi-ken, Japan
- National Cancer Center Hospital East ( Site 0002) Kashiwa, Chiba, Japan
- National Hospital Organization Shikoku Cancer Center ( Site 0008) Matsuyama, Ehime, Japan
- Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan